ANI Pharmaceuticals, Inc.

ANIP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$144,861$221,121$48,228$100,300
Short-Term Investments$6,307$0$0$0
Receivables$221,726$162,079$165,438$128,526
Inventory$136,782$111,196$105,355$81,693
Other Curr. Assets$18,008$25,420$25,240$11,256
Total Curr. Assets$527,684$519,816$344,261$321,775
Property Plant & Equip (Net)$56,863$44,593$43,246$52,671
Goodwill$59,990$28,221$28,221$27,888
Intangibles$541,834$209,009$251,635$294,122
Long-Term Investments$0$6,200$0$5,001
Tax Assets$85,106$90,711$81,363$67,936
Other NC Assets$12,220$5,872$11,361$2,205
Total NC Assets$756,013$384,606$415,826$449,823
Other Assets$0$0$0$0
Total Assets$1,283,697$904,422$760,087$771,598
Liabilities
Payables$45,656$36,683$29,305$22,967
Short-Term Debt$9,172$850$850$850
Tax Payable$6,749$8,164$0$3,667
Deferred Revenue$0$0$0$87
Other Curr. Liab.$132,103$99,780$69,284$59,966
Total Curr. Liab.$193,680$145,477$99,439$87,537
LT Debt$614,920$284,819$285,669$286,520
Deferred Rev, NC$0$0$0-$9,491
Deferred Tax Liab, NC$0$0$0$9,491
Other NC Liab.$46,567$16,527$36,439$38,801
Total NC Liab.$661,487$301,346$322,108$325,321
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$855,167$446,823$421,547$412,858
Equity
Pref Stock$24,850$24,850$24,850$24,850
Common Stock$2$2$1$1
Retained Earnings-$100,279-$80,132-$97,286-$47,765
AOCI$5,344$8,857$12,168-$3,055
Other Equity$498,613$504,022$398,807$384,709
Total Equity$428,530$457,599$338,540$358,740
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,283,697$904,422$760,087$771,598
Net Debt$479,231$64,548$238,291$187,070
ANI Pharmaceuticals, Inc. (ANIP) Financial Statements & Key Stats | AlphaPilot